TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←
▶ 78:40 · $ANDURIL · Anduril cited as outlier outcome from Founders Fund incubation at $60B valuation
episode briefing
Kleiner Perkins

The Sales Framework Every Founder Needs | Mark Roberge

2026-07-13 · 11 company · 11 thematic
sentiment
5 bull3 bear3 neu
speakers
mark roberge

Mark Roberge scaled HubSpot from $0 to $100M+ ARR as CRO, led its IPO, then joined Kleiner Perkins as a partner while teaching a popular sales course at HBS. He founded Stage 2 Capital (a $100M fund backed by 1,000+ CROs/CMOs) and recently launched Roadrunner, an AI-native CPQ startup backed by Founders Fund. Author of 'The Science of Scaling.'

quote
“Trey incubated Ando, they're raising at 60 billion. That's like public, right?”
—mark roberge

episode shorts · 3

What's Really Killing Retention?

Your First North Star Metric Matters Most

The Best Measure of Product-Market Fit

now playing · $ANDURIL
$ROADRUNNERbullish· high· posmark roberge
Roadrunner targets misunderstood CPQ market with AI-driven quoting automation
CPQ is a mission-critical, misunderstood category where incumbents have failed; AI enables modern pricing models (usage/consumption) that legacy systems cannot support, and the ac…
$GLEANneutral· medium· posmark roberge
Glean proved enterprise search timing works but now faces flanking from foundation models
Glean succeeded in a 'dead' category because timing, technology, and founder aligned, catalyzing competitor interest from Anthropic, Perplexity, OpenAI, and Microsoft; the moat no…
$RIPPLINGbullish· mediummark roberge
Rippling referenced as unique compound startup at scale with no historical precedent
Rippling's compound product strategy at scale has no historical precedent, forcing Parker Conrad to invent the playbook in real time — a pattern Mark sees across generational comp…
$CRM···bearish· mediummark roberge
Salesforce faces innovator's dilemma in CPQ as AI enables new entrants
Salesforce must choose between cannibalizing its own CPQ revenue or ceding the high-end market to AI-native entrants; the build-vs-buy calculus for enterprises is shifting but mis…
$ANTHROPICneutral· mediummark roberge
Foundation models enable internal build threat but vertical apps retain workflow and compliance moats
Claude and similar models lower the barrier for enterprises to build internal tools like CPQ, but the complexity of data models, pricing engines, multi-stakeholder workflows, inte…
$GLEANneutral· mediummark roberge
Glean faces intensifying competition from foundation model providers in enterprise search
Glean proved enterprise search viability despite skepticism, but now faces flanking competition from Anthropic, OpenAI, Perplexity, and Microsoft; the competitive race has shifted…
$SIERRAbearish· highmark roberge
Sierra and Harvey show 'groupon-like' growth with weak unit economics and PLG distribution risk
Fast-growing AI application companies like Sierra and Harvey are distributing through PLG motions inherited from Dropbox 2010 that attract SMB experimentation budgets, not product…
$HARVEYbearish· highmark roberge
Harvey grouped with Sierra as AI app with questionable unit economics behind PLG growth
Harvey's rapid growth relies on PLG distribution to legal professionals using experimentation budgets rather than production deployments, creating revenue that may not sustain whe…
$FOUNDERS-FUNDbullish· high· posmark roberge
Founders Fund leads Roadrunner Series A for long-term partnership over valuation optimization
Founders Fund's persistence and track record (incubating Anduril, early in Rippling/Figma/Slack) signaled deep understanding of messy early-stage scaling, making them the right pa…
$ANDURILbullish· mediummark roberge
Anduril cited as outlier outcome from Founders Fund incubation at $60B valuation
Anduril's trajectory from incubation to $60B valuation exemplifies the outlier outcomes possible when exceptional founders pair with patient, long-term capital that understands sc…
$STAGE-2-CAPITALbullish· high· posmark roberge
Stage 2 Capital closes $100M Fund IV with 1,000+ CRO/CMO LPs for go-to-market expertise
Stage 2 Capital's LP base of 1,000+ sales and marketing executives creates a unique go-to-market value-add platform for portfolio companies across any B2B sector, differentiating…